SAN FRANCISCO, March 13, 2017 /PRNewswire/ -- Symic Bio, a biopharmaceutical company focused on matrix biology that is developinga new category of therapeutics, today announced that Rinko Ghosh, President and Chief Business Officer, will present an overview of current programs at the upcoming 11th Annual BIO-Europe Spring Conference.
Date: Tuesday, March 21, 2017
Time: 11:45 a.m. CET
Location: CCIB Convention Centre, Barcelona, Spain
About Symic Bio
Symic Bio is a biopharmaceutical company focused on matrix biology that is developing a new category of therapeutics. These therapeutics, with potential applications in a wide variety of disease states, are inspired by naturally occurring macromolecules that play key regulatory roles within the extracellular matrix. Symic Bio currently has two clinical candidates: SB-030, which will initially target the prevention of peripheral vein graft failure and SB-061, directed at disease modification and pain management in the treatment of osteoarthritis. In addition, Symic Bio is investigating applications in the areas of fibrosis, oncology and diseases of the central nervous system. For additional information please visit the company's website at www.symic.bio, LinkedIn page at www.linkedin.com/company/symic-bio or follow on Twitter at www.twitter.com/symicbio.
Investor ContactsGitanjali Jain OgawaThe Trout Group(646) email@example.com
Media ContactsDavid Schull or Rich AllanRusso Partners, LLC(212) 845-4271(646) firstname.lastname@example.org email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/symic-bio-to-present-at-the-11th-annual-bio-europe-spring-conference-300422263.html
SOURCE Symic Bio
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All